These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15246221)

  • 21. [Liver-protective substances, dietary treatment and cures in the treatment of hepatic diseases (author's transl)].
    Egger G
    Ther Umsch; 1978 Sep; 35(9):761-5. PubMed ID: 360478
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reduced protein intake is justified only in selected cases].
    Holmqvist O
    Lakartidningen; 1996 Apr; 93(14):1318, 1320. PubMed ID: 8656858
    [No Abstract]   [Full Text] [Related]  

  • 23. How are normal, high- or low-protein diets defined?
    Westerterp-Plantenga MS
    Br J Nutr; 2007 Feb; 97(2):217-8. PubMed ID: 17298688
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of CLA at different dietary fat levels on the nutritional status of rats during protein repletion.
    Andreoli MF; Scalerandi MV; Borel IM; Bernal CA
    Nutrition; 2007; 23(11-12):827-35. PubMed ID: 17869484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic low intake of protein or vitamins increases the intestinal epithelial cell apoptosis in Wistar/NIN rats.
    Bodiga VL; Boindala S; Putcha U; Subramaniam K; Manchala R
    Nutrition; 2005 Sep; 21(9):949-60. PubMed ID: 16039830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of a very-low-protein diet in the elderly: what are the options?
    Misra M; Nolph K
    Am J Kidney Dis; 2008 Mar; 51(3):530; author reply 530-1. PubMed ID: 18295071
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficiency of includes of bioactive substances in diet of patient with hepatic encephalopathy].
    Kaziulin AN; Petukhov AB; Kucheriavyĭ IuA
    Vopr Pitan; 2006; 75(2):40-4. PubMed ID: 16729760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What does the term "diabetic kidney disease" mean and what is the dietary intervention?
    Marcason W
    J Am Diet Assoc; 2008 Jul; 108(7):1268. PubMed ID: 18589038
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dietetic manipulations in patients with hepatic encephalopathy].
    Uribe M; Morán S; de la Mora G
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):74-8. PubMed ID: 7916474
    [No Abstract]   [Full Text] [Related]  

  • 30. Energy restriction but not protein source affects antioxidant capacity in athletes.
    Rankin JW; Shute M; Heffron SP; Saker KE
    Free Radic Biol Med; 2006 Sep; 41(6):1001-9. PubMed ID: 16934684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet.
    Mamo JC; James AP; Soares MJ; Griffiths DG; Purcell K; Schwenke JL
    Eur J Clin Nutr; 2005 Oct; 59(10):1142-8. PubMed ID: 16015257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino-acid depletion induced by abnormal amino-acid conjugation and protein restriction in isovaleric acidemia.
    Loots DT; Mienie LJ; Erasmus E
    Eur J Clin Nutr; 2007 Nov; 61(11):1323-7. PubMed ID: 17299485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic effects of branched-chain amino acids and keto acids: mechanisms independent of protein intake?
    Zakar G
    J Ren Nutr; 2009 Sep; 19(5 Suppl):S25-6. PubMed ID: 19712872
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein intake and chronic kidney disease: literature review, 2003 to 2008.
    Aparicio M
    J Ren Nutr; 2009 Sep; 19(5 Suppl):S5-8. PubMed ID: 19712877
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein recommendations for individuals with CKD stages 1-4.
    Stall S
    Nephrol Nurs J; 2008; 35(3):279-82. PubMed ID: 18649589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary management of liver disease.
    Bateman EC
    Proc Nutr Soc; 1979 Dec; 38(3):331-6. PubMed ID: 531026
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of maternal dietary manipulation during different periods of pregnancy on hepatic glucogenic capacity in fetal and pregnant rats near term.
    Franko KL; Forhead AJ; Fowden AL
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):555-62. PubMed ID: 19179059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
    Sutton D; Higgins B; Stevens JM
    J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statistical appraisal of the routine use of a therapeutic diet in a hospital environment].
    Greco AM; Falconi C; Boschi V; Bozza P; Nastasi A
    Minerva Dietol Gastroenterol; 1978; 24(4):333-8. PubMed ID: 757277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.